Anxiety and Related Sleep Disorders - Eastern Asia

Eastern Asia

Revenue in the Anxiety and Related Sleep Disorders market is projected to reach US$1.15bn in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.85%, resulting in a market volume of US$1.20bn by 2029.
In global comparison, most revenue will be generated in the United States (US$3,213.00m in 2024).
In relation to total population figures, per person revenues of US$20.67 are generated in 2024.

Key regions: China, United States, Germany, India, Canada

Market

Region

Region comparison

Currency

Analyst Opinion

The Anxiety and Related Sleep Disorders market in Eastern Asia is experiencing significant growth due to changing customer preferences and increasing awareness of mental health issues in the region. Customer preferences in Eastern Asia have shifted towards a greater focus on overall well-being and mental health. As the region becomes more urbanized and people lead increasingly stressful lives, there is a growing demand for products and services that address anxiety and sleep disorders. Consumers are seeking out solutions that can help them relax, reduce stress, and improve their sleep quality. This has led to an increase in the adoption of anxiety and sleep disorder treatments and therapies in the region.One of the key trends in the market is the rising popularity of natural and holistic remedies for anxiety and sleep disorders. Consumers in Eastern Asia are gravitating towards products that are perceived to be more natural and have fewer side effects. This has led to an increase in the demand for herbal supplements, aromatherapy, and traditional Chinese medicine-based treatments. Manufacturers and service providers in the region are capitalizing on this trend by offering a wide range of natural and holistic options to cater to the growing demand.Another trend in the market is the growing use of technology to address anxiety and sleep disorders. Eastern Asia is known for its technological advancements, and consumers in the region are increasingly turning to digital solutions for managing their mental health. Mobile applications, wearable devices, and online therapy platforms are gaining popularity as convenient and accessible tools for anxiety and sleep disorder management. This trend is expected to continue as technology continues to advance and become more integrated into people's daily lives.In addition to changing customer preferences, there are also local special circumstances that contribute to the growth of the Anxiety and Related Sleep Disorders market in Eastern Asia. The high levels of stress and pressure in the region, particularly in countries like Japan and South Korea, have led to a higher prevalence of anxiety and sleep disorders. The fast-paced and competitive nature of these societies has created a need for effective solutions to manage mental health issues.Underlying macroeconomic factors also play a role in the growth of the market. Eastern Asia has experienced significant economic growth in recent years, leading to increased disposable income and healthcare spending. As people become more affluent, they are willing to invest in their mental well-being and seek out treatments for anxiety and sleep disorders. The growing middle class in the region is driving the demand for these products and services.Overall, the Anxiety and Related Sleep Disorders market in Eastern Asia is growing due to changing customer preferences, increasing awareness of mental health issues, local special circumstances, and underlying macroeconomic factors. As the region continues to develop and urbanize, the demand for products and services that address anxiety and sleep disorders is expected to further increase.

Methodology

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.